Skip to main content

Table 1 Difference of clinical features between HCC patients at low and high stages of TNM (AJCC).

From: Perioperative dynamic alterations in peripheral regulatory T and B cells in patients with hepatocellular carcinoma

Variables

Mean Rank

P

 

Stage Low

Stage High

 

Platelet ×109/L

16.77

23.00

0.034

Thrombocytocrit %

17.19

21.90

0.027

Cystatin C mg/L

16.08

24.80

0.003

Albumin/Globin

16.38

24.00

0.032

High density lipoprotein mmol/L

15.88

25.30

0.001

α-fetoprotein ng/ml

16.46

23.80

0.046

Ferritin ng/ml

15.62

26.00

0.004

Numbers of up-regulated tumor markers

15.48

26.35

0.003

Multiple Satellite nodules

16.77

23.00

0.053

Tumor encapsulation

16.88

22.70

0.022

score of Pathology section

15.58

26.10

0.007

Score of Tumor markers

16.35

24.10

0.042

Total score

16.27

24.30

0.040

  1. Stage low: TNM (AJCC) stage I. Stage high: TNM (AJCC) stage II-IV.
  2. HCC: Hepatocellular carcinoma; TNM (AJCC): Tumor-Node-Metastasis Staging System (American Joint Committee on Cancer).